A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability StudyJudith J. Prochaska, Athena Robinson, Sarah Pajarito et al.|Journal of Medical Internet Research|2021Cited by 257
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemicJudith J. Prochaska, Athena Robinson, Dale Dagar Maglalang et al.|Drug and Alcohol Dependence|2021Cited by 92
A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosaDebra L. Safer, Thomas Najarian, Shebani Sethi et al.|International Journal of Eating Disorders|2019Cited by 67
Demographic and clinical characteristics associated with anxiety and depressive symptom outcomes in users of a digital mental health intervention incorporating a relational agentEmil Chiauzzi, Valerie L. Forman‐Hoffman, Andre Williams et al.|BMC Psychiatry|2024Cited by 18